Analyst Price Targets — KVUE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 21, 2026 10:03 am | — | Barclays | $19.00 | $19.02 | TheFly | Kenvue price target raised to $19 from $18 at Barclays |
| July 16, 2026 12:10 pm | — | UBS | $20.00 | $18.91 | TheFly | Kenvue price target raised to $20 from $18 at UBS |
| April 14, 2026 12:53 pm | — | Barclays | $18.00 | $17.39 | TheFly | Kenvue price target lowered to $18 from $19 at Barclays |
| February 18, 2026 12:42 pm | — | UBS | $19.00 | $18.41 | TheFly | Kenvue price target raised to $19 from $17 at UBS |
| February 18, 2026 12:10 pm | — | Canaccord Genuity | $18.00 | $18.41 | TheFly | Kenvue price target raised to $18 from $17 at Canaccord |
| January 30, 2026 2:04 am | — | Jefferies | $18.00 | $17.20 | TheFly | Kenvue downgraded to Hold from Buy at Jefferies |
| October 29, 2025 10:27 am | — | Canaccord Genuity | $15.00 | $14.51 | TheFly | Kenvue downgraded to Hold from Buy at Canaccord |
| October 28, 2025 4:56 pm | Javier Escalante | Evercore ISI | $18.00 | $14.50 | StreetInsider | Evercore ISI Warns on Kenvue Inc (KVUE) Amid 3.5pct Decline: 'It's not just Tylenol' |
| October 27, 2025 9:42 am | — | Jefferies | $23.00 | $15.00 | StreetInsider | Kenvue Inc (KVUE) PT Lowered to $23 at JefferiesMember Login |
| October 24, 2025 11:18 am | — | Deutsche Bank | $18.00 | $15.07 | TheFly | Kenvue price target lowered to $18 from $20 at Deutsche Bank |
Latest News for KVUE
Australia's competition regulator on Wednesday approved Kimberly-Clark's proposed $40 billion takeover of Kenvue , on condition the company divests Kenvue's Carefree and Stayfree period care brands in the country to address competition concerns.
Kimberly-Clark has asked EU regulators permission for its proposed $40 billion takeover of Tylenol maker Kenvue, documents on the EU Commission's website showed.
Callan Family Office LLC bought a new position in shares of Kenvue Inc. (NYSE: KVUE) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor bought 43,671 shares of the company's stock, valued at approximately $835,000. A number of other institutional investors have also added to or
AssuredPartners Investment Advisors LLC acquired a new position in shares of Kenvue Inc. (NYSE: KVUE) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 32,710 shares of the company's stock, valued at approximately $625,000. A number of other institutional
B and T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Kenvue Inc. (NYSE: KVUE) during the undefined quarter, according to its most recent 13F filing with the SEC. The firm acquired 265,605 shares of the company's stock, valued at approximately $5,076,000. A number of other large investors
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.